Nick Green

Today we officially kick off our $2M pre seed round for Salubrum (Backed by Forum Ventures), supported by Forum Ventures, Coeus Collective Ventures, and Draper House Americas. Healthcare companies spend over $30B a year trying to acquire patients. The problem is not media. The problem is timing. Every time a patient approaches a healthcare decision a moment opens. Which doctor to see. Which procedure to pursue. Which treatment to start. For the companies involved in that decision, knowing that moment exists is incredibly valuable. Salubrum (Backed by Forum Ventures) is building the intelligence layer that maps those decision moments across the U.S. patient population. Our system aggregates large healthcare datasets covering 300M+ patient identities and uses them to predict when individuals are approaching important healthcare decisions. That signal can then be used by providers, pharma companies, payers, and other healthcare organizations trying to reach patients at the right time. Our first wedge is patient acquisition for healthcare providers and brands, but the underlying intelligence layer has much broader applications wherever patient behavior influences economic decisions. Over the past months we have quietly built the foundation. • Early pilots validating our patient intent scoring system • Distribution partnerships forming across healthcare platforms • Backed by Forum Ventures, Coeus Collective Ventures, Draper House Americas, NEXT Canada and Metta World Peace Starting tomorrow we will be meeting investors as part of the Forum Ventures showcase. If you are an investor interested in building with us get in touch. Calendly: https://lnkd.in/e5j-VvGC Investor Memo: https://lnkd.in/e5HyemAp

95

6 Comments

Midi Health just raised a $100M Series D and became the first menopause unicorn. This marks Actions Capital (fka K50 Ventures)'s ninth unicorn on the platform AND first investment for the Actions Growth Co-investment platform! We first met Joanna Strober in 2021 when we invested in the pre-seed, thanks to an intro from portfolio founder, Sarah Adler, PsyD (thanks Sarah!!). To me, the problem was staggering: 45 million women in the U.S. seeking care for menopause symptoms and not getting treatment, only 500 certified menopause providers in the entire country, 97% of midlife women without an OB/GYN, and an entire healthcare system that essentially told women to “tough it out”. Joanna had lived this problem herself, spending over a year searching for care, driving an hour to see a specialist, paying out of pocket, etc., and asked the question that would become Midi: Why isn't expert care for women at midlife easily accessible and covered by insurance? What started as a virtual care clinic has become the platform redefining how midlife women access healthcare in this country: • 25,000+ women receiving care every week. • Insurance-covered expert care in all 50 states. • Fortune 100 employers offering Midi as a health benefit. • Partnerships with major health systems and benefits providers nationwide. • Care that has expanded well beyond menopause into the full spectrum of midlife women's health. This $100M Series D round at $1B valuation was led by Goodwater Capital with Serena Ventures, Foresite Capital, and earlier investors including GV, Emerson Collective, SemperVirens, McKesson Ventures, AVP, and Felicis participating. Congrats to Joanna Strober, Sharon Meers, Jill Herzig, Kathleen Jordan, MD, Mindy Goldman, and the entire Midi Health team. You're no longer proving a concept. You're scaling a healthcare organization that women rely on every day. Let’s cook!

101

4 Comments

🥾 #bootstrapping as a mindset should be ephemeral, one that requires a deliberate transition away from as a business enters sustained growth Appointing an established auditor is often regarded as a luxury and not part of bootstrapping Audits discipline a business - to be methodical, thorough and deliberate - traits that acquirers often seek in due diligence After all, "What gets inspected, gets respected," Anon We will share the traits of venture businesses sought and respected by MNC acquirers, join us if your business is out of the #bootstrapping mindset #fulfillingpotential #hepmil #oobmil

24

1 Comment

What if the next $1B health company isn’t built in SF… but in Paris? Max Berthelot is doing exactly that with Lucis (YC X25): AI + longitudinal blood testing to catch disease years before symptoms. Preventive health isn’t just wellness anymore… It’s venture-scale. In this episode, we break down: - Why blood data, not wearables, is the real gold rush. - The "Blue Ocean" arbitrage of building in Europe. - How to maintain SF velocity in a Paris office. If you think the next healthcare giant looks like a hospital, then you're looking in the wrong century. 🔗 Link to full episode in the comment section

43

3 Comments

I’m thrilled to announce defy.vc’s investment in Birches Health as part of their $20M combined Seed and Series A funding round, alongside incredible partners like AlleyCorp, General Catalyst, Will Ventures, and others. As someone deeply passionate about backing companies that tackle important problems for our society, I couldn’t be more excited about what Birches is building—a national virtual clinic dedicated to treating gambling addiction and related behavioral disorders like gaming, sex, porn, and internet addictions. What excites me most is Birches’ innovative health assurance model: proactive, accessible, and affordable care that’s evidence-based and delivered right at home. With the explosion of legal sports betting—think nearly $1.5 billion wagered on this year’s Super Bowl alone—we’re staring down a looming public health emergency. Traditional options like hotlines or generic therapy fall short for this high-acuity issue, but Birches changes that by offering specialized therapy from trained clinicians, multimodal treatment, and peer support, all covered by major insurers like United Healthcare, Cigna, Aetna, and Blue Cross Blue Shield. It’s available in all 50 states, breaking down geographical and financial barriers that have left so many without help. The impact is already profound: 96% of patients report an improved quality of life, and 94% give Birches a 5/5 rating. By partnering with state governments, payors, and policymakers, Birches is pushing gambling addiction into the spotlight of behavioral health conversations, where it’s been neglected for too long—often leading to shame, worsened outcomes, and higher suicidality risks. This funding will supercharge their growth: expanding the provider network, boosting clinical excellence, scaling infrastructure, and deepening insurance and state partnerships to meet surging demand. Very excited to partner with Elliott Rapaport and the entire Birches team! See more about our POV in the blog post linked in the comments. #GamblingAddiction #BehavioralHealth #HealthTech #VentureCapital #Innovation

159

10 Comments

Yesterday's seed market was built on three constraints: Products were hard to build. Traction took time. VCs were hesitant to underwrite day zero risk. Those constraints created a unique market. Today, all three are dissolving.

32

8 Comments

We're excited to lead Clarium's $27M Series A, with participation from General Catalyst, AlleyCorp, Kaiser Permanente Ventures, TMC Ventures, and 1984 Ventures. Healthcare supply chains represent a critical but overlooked component of patient care. In an industry where nearly $30 billion of the $140 billion spent annually on medical supplies is wasted, Clarium is building something revolutionary: Astra OS, the first comprehensive resiliency platform for healthcare supply chains. What makes Clarium special is their holistic approach. While most solutions offer band-aids for specific pain points, Clarium's platform unifies fragmented data across providers, manufacturers, and distributors, applying AI to help health systems anticipate disruptions before they impact patient care. In today's world of climate disasters, global consolidation, and increasing tariffs, supply chain resilience isn't optional—it's essential. When Hurricane Helene recently knocked out a facility producing 70% of America's saline supply, Clarium's platform gave customers critical early warnings and alternative supplier recommendations. Founder Steve Liou brings unique insights from his background in healthcare investment banking, VC, and portfolio management at Point72, Citadel, and Millennium. He's built a team that understands both the complexities of healthcare operations and the power of modern technology. We're proud to back Steve and the entire Clarium team as they build the infrastructure for a smarter, more efficient healthcare future. p.s. If you want a free tariff assessment for your health system, get in touch! CC Northzone Wendy Xiao Nick Boesel

50

3 Comments

I’m so proud that Hyphen Capital has been a backer of Tim Hwang and Jonathan Chen since the beginning of Nitra. They had big ambitions to modernize the archaic back office of healthcare practices from fax machines to AI. It’s been amazing to see their growth from processing zero transactions to over a billion dollars and they’re just getting started.

40

3 Comments

An often overlooked truth in venture: founder health is company health. In our latest Warrior Guide, we partnered with Noah Shanok, founder and first CEO of Stitcher (acquired by SiriusXM), early StubHub exec (acquired by eBay), and Benchmark & NEA-backed entrepreneur, to share the parts of founder life we should talk about more. This guide isn’t a checklist. It’s lived experience, and it's brutal, honest, and practical. From near-burnout during a Series A raise to the daily work of recovering clarity, Noah shared strategies that go deeper than platitudes: 🫂 Building a trusted peer support circle ⏰ Creating routines that actually work in startup life 🧠 Recognizing when to ask for help (and why it’s a strength, not a weakness) If you’re leading a company and finding it harder to lead yourself some days, you’re not alone. This one’s for you! Read the full warrior guide at the link in the comments. Founders- what are the mental resilience habits you’ve built into your journey? We'd love to hear from you.

24

2 Comments

Thrilled to announce that Together Fund is investing in Sentra, alongside a16z speedrun! You track results in Jira. Decisions in Notion. Conversations in Slack. But the reasoning, the debates, trade-offs, and context behind why you chose A over B, disappears into what we call "Dark Matter." A decision made in March looks insane by July because no one remembers the constraints that made it smart. I lived this firsthand at Twitter scaling from 800 to 8,000 employees, and at Google while launching AI Overviews to billions at planet scale. The problem isn't process. Process is compensation for something deeper: organizational amnesia. An organization’s "Systems of Record" doesn’t solve this, they encode it. They store what happened, never why. That's why we are investing in Sentra. Sentra is the always-on collective memory that eliminates organizational amnesia by maintaining accurate context for all members and agents, functioning as an operational nervous system. It connects to every channel where work happens, meetings, Slack, email, code commits, docs, calendars, and treats them not as artifacts to search, but as living signals to synthesize. The fleeting and the permanent, unified into a memory that understands. The founding team is built for this: - Jae Gwan Park (CEO): Product-first founder, memory systems research at UofT and MIT - Ashwin Gopinath (CSO): Former MIT professor, created "Reflexion" (NeurIPS 2023), agents that learn from mistakes, 2x founder - Andrey Starenky (CTO): Early Vapi engineer, ex-IBM, built to process enterprise-scale data firehose Together is an operator-led fund. We invest in problems we've lived. This is one of them. Many congrats Jae, Ashwin and Andrey, we are so excited to partner with you! Read the full thesis: https://lnkd.in/gixj9cE4 Book a demo: https://www.sentra.app/ #OrganizationalMemory #AI #Sentra #TogetherFund #a16z #ContextGraphs

71

3 Comments

Sometimes promising startups get off on the wrong foot with their VC fundraising effort because they step into a trap that signals naiveté. Three very simple starter suggestions for every founder looking to raise early-stage VC: 1. Target a common round size ($3M Seed, $10M Series A) 2. Stay silent on valuation until you have a term sheet 3. Define what the capital enables (e.g., revenue milestone) https://lnkd.in/gEfArG78

38

4 Comments